Amifostine: Clinical Trials

76 trials of Amifostine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

52 completed, 10 terminated, 10 unknown, 4 withdrawn. 51 Phase 2, 26 Phase 1, 8 Phase 3, 2 Phase 4, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 251Completed 34, Unknown 8, Terminated 7, Withdrawn 2
Phase 126Completed 19, Unknown 4, Terminated 2, Withdrawn 1
Phase 38Completed 7, Terminated 1
Phase 42Completed 1, Withdrawn 1
Not applicable1Completed 1

Follow Amifostine: new trials by email Literature Review of Amifostine trials Research Report on Amifostine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer
Radiation, Capecitabine, Irinotecan - Locally Advanced Rectal Cancer
Phase 2UnknownFudan University1602018-05-282019-01-23
Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy
Cisplatin, Amifostine - Lung Cancer
Phase 1CompletedM.D. Anderson Cancer Center72014-08-202023-09-14
A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity
Amifostine - Rectal Cancer
Phase 2UnknownChinese Academy of Medical Sciences402012-02-012013-08-15
High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors
Amifostine - Solid Tumors, Brain Tumors
Phase 2TerminatedChildren's Hospital Medical Center, Cincinnati22010-12-132022-01-25
A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia
Amifostine, CyberKnife stereotactic radiosurgery - Trigeminal Neuralgia
Phase 3TerminatedStanford University172008-09-012017-04-04
Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma
Extrapleural pneumonectomy (EPP), Cisplatin, gemcitabine - Malignant Pleural Mesothelioma
Phase 1CompletedBrigham and Women's Hospital1412007-11-012017-01-23
Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment
Amifostine, Intensity- Modulated Radiation Therapy - Head and Neck Cancer
Phase 2TerminatedM.D. Anderson Cancer Center32006-12-012012-08-07
A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer
Amifostine - Colorectal Cancer
Phase 2TerminatedUniversity of Cincinnati42006-10-012023-08-01
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
Amifostine, Cisplatin, Fluorouracil - Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7
Phase 3CompletedChildren's Oncology Group1112006-02-202022-10-25
Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia
exercise intervention, amifostine trihydrate, therapeutic dietary intervention - Dysphagia, Head and Neck Cancer
Phase 2TerminatedVanderbilt-Ingram Cancer Center412006-01-012017-06-20
Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma
melphalan, amifostine trihydrate, peripheral blood stem cell transplantation - Refractory Multiple Myeloma, Stage II Multiple Myeloma
Phase 3CompletedFred Hutchinson Cancer Center1302005-07-012015-08-21
Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery
recombinant interferon alfa-2b, amifostine/azacitidine - Recurrent Melanoma, Recurrent Renal Cell Cancer
Phase 1CompletedNational Cancer Institute (NCI)422005-07-012013-05-03
Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
amifostine trihydrate - Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
Phase 2CompletedChildren's Oncology Group102005-01-012014-02-13
Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia
Idarubincin and Amufostine (Ethyol), Idarubincin - Leukemia, Acute Myeloid Leukemia
Phase 1 / Phase 2CompletedMedImmune LLC542004-07-012009-01-29
Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
Amifostine - Breast Cancer, Lung Cancer
Phase 2CompletedM.D. Anderson Cancer Center242004-05-012012-10-17
Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation
filgrastim, amifostine trihydrate, melphalan - Drug/Agent Toxicity by Tissue/Organ, Multiple Myeloma and Plasma Cell Neoplasm
Phase 1TerminatedEastern Cooperative Oncology Group82004-01-222023-06-18
Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer
Amifostine - Esophagitis, Pneumonitis
Phase 2CompletedMedImmune LLC1302003-11-012007-08-21
Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities
Ethyol (Amifostine) - Head and Neck Cancer, Lung Cancer
Not applicableCompletedThe Dale & Frances Hughes Cancer Center202003-06-012005-09-27
Randomized Amifostine For SCCHN
Amifostine, Carboplatin, Paclitaxel - Chemotherapeutic Agent Toxicity, Head and Neck Cancer
Phase 2CompletedDana-Farber Cancer Institute582003-05-012017-01-04
Amifostine for Head and Neck Irradiation in Lymphoma
Amifostine, Radiation Therapy - Lymphoma, Hodgkin's Disease
Phase 2CompletedDana-Farber Cancer Institute752003-05-012009-11-02

Showing 20 of 76. Sign in to see all of them.

Conditions studied

Drug-Related Side Effects and Adverse Reactions (19)  ·  Head and Neck Neoplasms (15)  ·  Lung Neoplasms (12)  ·  Radiation Injuries (11)  ·  Ovarian Neoplasms (10)  ·  Leukemia (9)  ·  Myelodysplastic Syndromes (9)  ·  Carcinoma, Non-Small-Cell Lung (8)  ·  Carcinoma, Ovarian Epithelial (8)  ·  Squamous Cell Carcinoma of Head and Neck (8)  ·  Leukemia, Myeloid, Acute (7)  ·  Hodgkin Disease (6)  ·  Lymphoma (6)  ·  Lymphoma, Non-Hodgkin (6)  ·  Sarcoma (6)

Sponsors

Children's Oncology Group (4)  ·  Dana-Farber Cancer Institute (4)  ·  M.D. Anderson Cancer Center (4)  ·  National Cancer Institute (NCI) (4)  ·  University of Arizona (3)  ·  European Organisation for Research and Treatment of Cancer - EORTC (2)  ·  Gynecologic Oncology Group (2)  ·  Jonsson Comprehensive Cancer Center (2)  ·  MedImmune LLC (2)  ·  Radiation Therapy Oncology Group (2)  ·  Rush University Medical Center (2)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (2)  ·  University of Alabama at Birmingham (2)  ·  University of Chicago (2)  ·  Washington University School of Medicine (2)

Countries

United States (69)  ·  Australia (5)  ·  Canada (5)  ·  Puerto Rico (3)  ·  Switzerland (3)  ·  Belgium (2)  ·  China (2)  ·  France (2)  ·  Netherlands (2)  ·  Austria (1)  ·  Czechia (1)  ·  Israel (1)  ·  Italy (1)  ·  Portugal (1)  ·  Slovakia (1)

Top investigators

Philip D. Bonomi, MD (2)  ·  Abdul-Kader Souid (1)  ·  Alan F. List, MD (1)  ·  Amar Gajjar, MD (1)  ·  Andre A. Abitbol, MD (1)  ·  Andrea K. Ng, MD (1)  ·  Arthur Forman, MD (1)  ·  Barbara A. Murphy, MD (1)  ·  Benjamin Movsas, MD (1)  ·  Carlos Rodriguez-Galindo (1)  ·  Charles W. Taylor, MD (1)  ·  Christos E. Emmanouilides, MD (1)  ·  Clara Choi (1)  ·  David A. Fishman, MD (1)  ·  David H. Moore, MD (1)

Results publications

PMID 11917283, PMID 14615449, PMID 14727242, PMID 14767498, PMID 15721401, PMID 15800308, PMID 15999362, PMID 16015544, PMID 16029787, PMID 16116597, PMID 16382125, PMID 16730138, PMID 17012043, PMID 17336213, PMID 17398031, PMID 17855015, PMID 18309946, PMID 18501528, PMID 19634161, PMID 19858383, PMID 21681928, PMID 21892091, PMID 23477890, PMID 31553639, PMID 31657981, PMID 39285365, PMID 9771955

NIH funding

P01CA075606 (2), P30CA006516 (2), U10CA098543 (2), P30CA016056 (1), P30CA016087 (1), P30CA016672 (1), P30CA023074 (1), P30CA033572 (1), P30CA046592 (1), U01CA097452 (1), U10CA021115 (1), U10CA032102 (1), U10CA180886 (1)